BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Mike Grey will speak on "What Are the Funding Sources and How to Apply" at the American Chemical Society meeting in San Diego, CA
News | 10. 09. 2010
